{"id":"NCT01170221","sponsor":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","briefTitle":"TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.","officialTitle":"A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08-15","primaryCompletion":"2011-09-30","completion":"2011-09-30","firstPosted":"2010-07-27","resultsPosted":"2014-09-03","lastUpdate":"2018-08-29"},"enrollment":667,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Skin and Subcutaneous Tissue Bacterial Infections"],"interventions":[{"type":"DRUG","name":"TR-701 FA","otherNames":["Tedizolid Phosphate","TR-700 active moiety"]},{"type":"DRUG","name":"Linezolid","otherNames":["Trade name = Zyvox","Generic name = linezolid"]}],"arms":[{"label":"TR-701 FA","type":"EXPERIMENTAL"},{"label":"Linezolid","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, double-blind, double dummy, multicenter Phase 3 study of oral TR-701 FA 200 mg once daily for 6 days versus oral ZyvoxÂ® (linezolid) 600 mg every 12 hours for 10 days for the treatment of ABSSSI in adults.\n\nApproximately 75 to 100 sites globally will participate in this study. Patients with an ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be randomized 1:1 to study treatment","primaryOutcome":{"measure":"Early Clinical Response Rate","timeFrame":"48-72 hours","effectByArm":[{"arm":"Tedizolid Phosphate","deltaMin":264,"sd":null},{"arm":"Linezolid","deltaMin":266,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":84,"countries":["United States","Argentina","Brazil","Canada","Czechia","Germany","Hungary","Latvia","Peru","Slovakia","Ukraine"]},"refs":{"pmids":["28264845","28003218","27530088","25421472","25246392","24450727","23403680"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":331},"commonTop":["Nausea","Headache","Diarrhea","Vomiting","Abscess"]}}